MedPath

OTSUKA AMERICA PHARMACEUTICAL

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

13

Active:0
Completed:13

Trial Phases

5 Phases

Phase 1:2
Phase 2:1
Phase 3:4
+2 more phases

Drug Approvals

1

FDA:1

Drug Approvals

Pranactin-Citric

Approval Date
Aug 24, 2009
FDA

Clinical Trials

Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials

Phase 3
4 (33.3%)
Phase 4
4 (33.3%)
Phase 1
2 (16.7%)
Not Applicable
1 (8.3%)
Phase 2
1 (8.3%)

POCone-UBiT-IR300 Pediatric Comparison Study

Phase 4
Completed
Conditions
Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
First Posted Date
2012-06-19
Last Posted Date
2015-02-23
Lead Sponsor
Otsuka America Pharmaceutical
Target Recruit Count
99
Registration Number
NCT01623154
Locations
🇺🇸

Miami Pediatric Gastroenterology, Miami, Florida, United States

🇺🇸

University of Texas School of Public Health, El Paso, Texas, United States

🇺🇸

Baylor College of Medicine, Houston, Texas, United States

Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia

Completed
Conditions
Euvolemic Hyponatremia
Hypervolemic Hyponatremia
First Posted Date
2010-11-15
Last Posted Date
2015-05-15
Lead Sponsor
Otsuka America Pharmaceutical
Target Recruit Count
5028
Registration Number
NCT01240668
Locations
🇺🇸

North America Research Institute, Azusa, California, United States

🇺🇸

Chrishard Medical Group, Inglewood, California, United States

🇺🇸

UCLA, Los Angeles, California, United States

and more 76 locations

Study for the Treatment of Crohn's Disease With Adacolumn

Phase 3
Completed
Conditions
Crohn's Disease
First Posted Date
2005-09-13
Last Posted Date
2009-04-07
Lead Sponsor
Otsuka America Pharmaceutical
Target Recruit Count
235
Registration Number
NCT00162942
Locations
🇺🇸

Mayo Clinic Scottsdale, Phoenix, Arizona, United States

🇺🇸

Capitol Gastroenterology Consultants Medical Group, Roseville, California, United States

🇺🇸

UCSF Mount Zion Medical Center, San Francisco, California, United States

and more 33 locations

Study for the Treatment of Ulcerative Colitis With Adacolumn

Phase 3
Completed
Conditions
Ulcerative Colitis
First Posted Date
2005-01-25
Last Posted Date
2008-09-08
Lead Sponsor
Otsuka America Pharmaceutical
Target Recruit Count
168
Registration Number
NCT00102193
Locations
🇺🇸

Mayo Clinic Scottsdale, Phoenix, Arizona, United States

🇺🇸

Providence Clinical Research, Burbank, California, United States

🇺🇸

University of California, San Francisco, San Francisco, California, United States

and more 34 locations

Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Phase 4
Completed
Conditions
Raynaud's Disease
First Posted Date
2002-11-11
Last Posted Date
2005-07-19
Lead Sponsor
Otsuka America Pharmaceutical
Target Recruit Count
75
Registration Number
NCT00048763
Locations
🇺🇸

Advanced Medical Clinical Therapeutics, Anchorage, Alaska, United States

🇺🇸

Advanced Medical Research Institute, Fresno, California, United States

🇺🇸

Madera Family Medical Group, Madera, California, United States

and more 15 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath